InspireMD, Inc.
- Jurisdiction
Israel - LEI
549300OQ16IJ5DIS5D30 - ISIN
US45779A8466 (NSPR )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. Read full profile
Fundamentals
- Net revenue
€6.03M - Gross margin
21.1% - EBIT
-€36.09M - EBIT margin
-598.8% - Net income
-€35.30M - Net margin
-585.6%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kester Thomas J | N/A |
|
|
|
|
| ROUBIN GARY S | N/A |
|
|
|
|
| Slosman Marvin | CEO and President |
|
|
|
|
| Stuka Paul | N/A |
|
|
|
|
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: August 5, 2025 (Q2 2025)